USFDA completes Ghaziabad plant inspection, no observations issued: Unichem
New Delhi: Drug firm Unichem Laboratories said it has not received any observations from the US health regulator after completion of inspection of its Ghaziabad facility in Uttar Pradesh.
The company's formulation manufacturing facility at Ghaziabad was inspected by the United States Food and Drug Administration (USFDA) from April 16, 2018, to April 20, 2018, Unichem Laboratories said in a BSE filing.
The inspection concluded with zero observations, it added.
"This inspection also covered one of the first to file molecules," Unichem Laboratories said.
completesGhaziabad plantinspectionno observationsUnichemUnichem LaboratoriesUnited States Food and Drug AdministrationUSFDAUttar Pradesh
Source : PTINext Story
NO DATA FOUND
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd